International Journal of Science and Research (IJSR)

International Journal of Science and Research (IJSR)
Since Year 2012 | Open Access | Fully Refereed | Peer Reviewed

ISSN: 2319-7064




Downloads: 3 | Weekly Hits: ⮙1 | Monthly Hits: ⮙1

Review Papers | Ayurveda | India | Volume 11 Issue 6, June 2022


Use of Shyama Trivrit (Operculinaturpetum, Linn.) in Various Disorder: An Ayurvedic Literary Review

Taiyeba Tahira [2] | Piyali Kundu [2] | P. B. Kar Mahapatra [3]


Abstract: The ancient Ayurvedic classics stated that when there is accumulation of morbid bio humours in the body they should be expelled out. For this, Ayurveda has given maximum importance to the srotosodhana activity for the clearance of morbid bio humours of the system which causing obstruction in srota (macro and micro channel) followed by mal circulation of nutrients to the organ and tissue of the body. Shyama - Trivrit is safe and widely used herbal drugs in Ayurveda, reported best sukhavirechakdravya used from ancient era to till date for cleaning of annavahasrotas (Gastro Intestinal Tract). The present work deals with the literary information in relation to the pharmacological properties action and their therapeutics effects which has been presented here in a methodical manner for better understanding of readers. Thus the main aim and objectives of this study is to bring enormous information of Shyama - Trivrit and to encourage the physicians and scholars for safe and rational use of the same drug in different disorder where srotosodhana (cleaning of channel) action is needed.


Keywords: Shyama - Trivrit, Rechana and sukhavirechana


Edition: Volume 11 Issue 6, June 2022,


Pages: 86 - 89


How to Cite this Article?

Taiyeba Tahira, Piyali Kundu, P. B. Kar Mahapatra, "Use of Shyama Trivrit (Operculinaturpetum, Linn.) in Various Disorder: An Ayurvedic Literary Review", International Journal of Science and Research (IJSR), Volume 11 Issue 6, June 2022, pp. 86-89, https://www.ijsr.net/get_abstract.php?paper_id=SR22527162414

How to Share this Article?

Enter Your Email Address






Top